A phase II trial of carboplatin in untreated patients with extensive stage small cell lung cancer
暂无分享,去创建一个
[1] P. Benfield,et al. Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer. , 1989, Drugs.
[2] M. Rozencweig,et al. Carboplatin: current status and future prospects. , 1988, Cancer treatment reviews.
[3] E. Alba,et al. Carboplatin, an active drug in advanced head and neck cancer. , 1986, Cancer treatment reports.
[4] H. Hansen,et al. Current status of research into small cell carcinoma of the lung: summary of the Second Workshop of the International Association for the Study of Lung Cancer (IASLC). , 1985, European journal of cancer & clinical oncology.
[5] H. Hansen,et al. Etoposide (VP-16) in the treatment of lung cancer. , 1983, Cancer treatment reviews.
[6] R. Ozols,et al. A Phase I and Pharmacokinetic Study of Diamminecyclobutanedicarboxylatoplatinum (NSC 241240) , 1983 .
[7] E. Gehan,et al. The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. , 1961, Journal of chronic diseases.
[8] J. Yarnold,et al. Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer. , 1985, Cancer treatment reports.
[9] A. Miller,et al. Reporting results of cancer treatment , 1981, Cancer.